THE WIRE · № 84604
Brayton Purcell LLP Welcomes Federal Bill Addressing Artificial Stone Silicosis Epidemic
01 THE MACHINE READ
WHY IT MATTERS.
Federal silicosis legislation could expand screening and treatment obligations, a legal and regulatory theme for stone fabrication employers.
Occupational health legislation with narrow sector reach
Committee action or passage of the bill
Bill may stall without floor vote
FULL DISPATCH
Silicosis Prevention and Treatment Act would expand screening, treatment, education, and patient care as California artificial stone fabrication workers face a growing number of cases NOVATO, Calif., Oct. 16, 2026 /PRNewswire/ -- Brayton Purcell LLP welcomes new federal legislation that...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
Youngstown Orthopaedic Associates Joins Cleveland Clinic and Dr. James D. Solmen Retires2026-10-16 17:54 UTC
City Therapeutics surges in market debut after upsizing $200M IPO2026-10-16 17:13 UTC
City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver2026-10-16 17:48 UTC
IPO market review: biotech leads a quiet week as Anthropic waits in the queue2026-10-16 17:38 UTC
Updated: City Therapeutics lands $200M IPO as it builds an Alnylam 2.0 in RNAi field2026-10-16 10:17 UTC
City’s IPO soars to $200M, with proceeds supporting thromboembolic disease pipeline2026-10-16 13:45 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.